A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age

Clinical trial NCT07742644 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07742644
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Measles Mumps Rubella Varicella (Chickenpox)Measles-Mumps-Rubella+Chickenpox Vaccine

Start date: 2026-08-11
Primary completion: 2028-06-27
Enrollment: 1860

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.